Huseyin Altaeh/LinkedIn
Mar 29, 2026, 15:59
Huseyin Altaeh: Transient Ischemic Attack as a Warning Sign of an Impending Stroke
Huseyin Altaeh, Staff Registered Nurse at Health Assurance Hospitals Company – DHAMAN, shared a post on LinkedIn:
“Transient Ischemic Attack (TIA) – ‘Mini Stroke’
What is TIA?
A Transient Ischemic Attack (TIA) is a temporary interruption of blood flow to the brain.
It causes stroke-like symptoms that resolve completely within minutes to hours (usually less than 1 hour).
Important: TIA is a warning sign of an impending stroke.
Clinical Features (Sudden onset)
- Unilateral weakness or numbness (face/arm/leg)
- Slurred speech or aphasia
- Vision loss or blurred vision
- Dizziness or loss of balance
- Sudden confusion
Duration
- Typically a few minutes to less than 1 hour
- By definition, no permanent neurological deficit
Why it matters
High risk of ischemic stroke, especially within 48 hours.
Requires urgent evaluation and management
- ED Workup
- CT brain / MRI
- ECG (rule out atrial fibrillation)
- Blood tests (glucose, lipids, coagulation)
- Carotid Doppler / CTA
Management
- Antiplatelet therapy (e.g., aspirin)
- Control hypertension, diabetes, hyperlipidemia
- Anticoagulation if atrial fibrillation present
- Lifestyle modification (stop smoking, diet)
Red flag
- Treat TIA as a medical emergency
- Do Not ignore symptoms even if they resolve
If you want, I can also make this into a ready-to-post medical infographic or short ER notes version .”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series